140 related articles for article (PubMed ID: 9711908)
1. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis.
Escribano L; Ocqueteau M; Almeida J; Orfao A; San Miguel JF
Leuk Lymphoma; 1998 Aug; 30(5-6):459-66. PubMed ID: 9711908
[TBL] [Abstract][Full Text] [Related]
2. Expression of the stem cell factor receptor C-KIT (CD117) in acute leukemias.
Sperling C; Schwartz S; Büchner T; Thiel E; Ludwig WD
Haematologica; 1997; 82(5):617-21. PubMed ID: 9407735
[TBL] [Abstract][Full Text] [Related]
3. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
[TBL] [Abstract][Full Text] [Related]
5. CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features.
Schmidt-Hieber M; Pérez-Andrés M; Paiva B; Flores-Montero J; Perez JJ; Gutierrez NC; Vidriales MB; Matarraz S; San Miguel JF; Orfao A
Haematologica; 2011 Feb; 96(2):328-32. PubMed ID: 20971816
[TBL] [Abstract][Full Text] [Related]
6. AlphaIIb integrin expression during development of the murine hemopoietic system.
Corbel C; Salaün J
Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
[TBL] [Abstract][Full Text] [Related]
7. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML.
Macedo A; Orfao A; Martínez A; Vidriales MB; Valverde B; López-Berges MC; San Miguel JF
Br J Haematol; 1995 Feb; 89(2):338-41. PubMed ID: 7532985
[TBL] [Abstract][Full Text] [Related]
9. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
[TBL] [Abstract][Full Text] [Related]
10. Common marmoset CD117+ hematopoietic cells possess multipotency.
Shimada S; Nunomura S; Mori S; Suemizu H; Itoh T; Takabayashi S; Okada Y; Yahata T; Shiina T; Katoh H; Suzuki R; Tani K; Ando K; Yagita H; Habu S; Sasaki E; Kametani Y
Int Immunol; 2015 Nov; 27(11):567-77. PubMed ID: 25977306
[TBL] [Abstract][Full Text] [Related]
11. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
12. Expression of high amounts of the CD117 molecule in a case of B-cell non-Hodgkin's lymphoma carrying the t(14:18) translocation.
Bravo P; Agustín BD; Bellas C; González D; Cámara C; Fuertes IF; Almeida J; Sanz RG; Orfao A; Escribano L
Am J Hematol; 2000 Apr; 63(4):226-9. PubMed ID: 10706768
[TBL] [Abstract][Full Text] [Related]
13. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT; Zander A
Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
[TBL] [Abstract][Full Text] [Related]
14. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.
Rosnet O; Bühring HJ; Marchetto S; Rappold I; Lavagna C; Sainty D; Arnoulet C; Chabannon C; Kanz L; Hannum C; Birnbaum D
Leukemia; 1996 Feb; 10(2):238-48. PubMed ID: 8637232
[TBL] [Abstract][Full Text] [Related]
15. Effects of mutant c-Kit in early myeloid cells.
Ashman LK; Ferrao P; Cole SR; Cambareri AC
Leuk Lymphoma; 1999 Aug; 34(5-6):451-61. PubMed ID: 10492068
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.
Macedo A; Orfao A; Ciudad J; Gonzalez M; Vidriales B; Lopez-Berges MC; Martínez A; Landolfi C; Cañizo C; San Miguel JF
Leukemia; 1995 Nov; 9(11):1896-901. PubMed ID: 7475281
[TBL] [Abstract][Full Text] [Related]
17. CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease.
Scolnik MP; Morilla R; de Bracco MM; Catovsky D; Matutes E
Leuk Res; 2002 Jul; 26(7):615-9. PubMed ID: 12008077
[TBL] [Abstract][Full Text] [Related]
18. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
19. C-kit receptor (CD117) expression in acute leukemia.
Valverde LR; Matutes E; Farahat N; Heffernan A; Owusu-Ankomah K; Morilla R; Catovsky D
Ann Hematol; 1996 Jan; 72(1):11-5. PubMed ID: 8605274
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
